【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 9
1.1 List of Tables 16
1.2 List of Figures 21
2 Introduction 22
2.1 Catalyst 22
2.2 Upcoming Reports 22
3 Disease Overview 23
3.1 Etiology and Pathophysiology 23
3.1.1 Etiology 23
3.1.2 Pathophysiology 24
3.2 Symptoms 25
4 Epidemiology 26
4.1 Disease Background 26
4.2 Risk Factors and Comorbidities 27
4.2.1 Psychiatric illness in first-degree relatives is a strong predictor of schizophrenia 28
4.2.2 Advancing paternal age increases the risk of schizophrenia in offspring 29
4.2.3 Psychiatric comorbidities are common in patients with schizophrenia 30
4.2.4 People with schizophrenia suffer from several medical comorbidities 31
4.3 Global Trends 34
4.3.1 US 37
4.3.2 5EU 38
4.3.3 Japan 41
4.4 Forecast Methodology 42
4.4.1 Sources Used 42
4.4.2 Sources Not Used 45
4.4.3 Forecast Assumptions and Methods, Prevalent Cases 45
4.5 Epidemiological Forecast of Schizophrenia (2012-2022) 47
4.5.1 Diagnosed Prevalent Cases of Schizophrenia 47
4.5.2 Age-Specific Prevalent Cases of Schizophrenia 49
4.5.3 Sex-Specific Prevalent Cases of Schizophrenia 51
4.5.4 Age-Standardized Diagnosed Prevalence of Schizophrenia 53
4.6 Discussion 54
4.6.1 Epidemiological Forecast Insight 54
4.6.2 Limitations of the Analysis 55
4.6.3 Strengths of the Analysis 56
5 Disease Management 57
5.1 Diagnosis 57
5.1.1 Subjective Assessments 58
5.1.2 Disease Subtypes 59
5.2 Treatment Overview 62
5.2.1 Treatment of Acute Agitation Associated with Schizophrenia 64
5.2.2 Maintenance Treatment of Schizophrenia 65
5.3 US 66
5.3.1 Diagnosis 66
5.3.2 Clinical Practice 66
5.4 France 67
5.4.1 Diagnosis 67
5.4.2 Clinical Practice 68
5.5 Germany 69
5.5.1 Diagnosis 69
5.5.2 Clinical Practice 69
5.6 Italy 71
5.6.1 Diagnosis 71
5.6.2 Clinical Practice 71
5.7 Spain 72
5.7.1 Diagnosis 72
5.7.2 Clinical Practice 72
5.8 UK 73
5.8.1 Diagnosis 73
5.8.2 Clinical Practice 74
5.9 Japan 75
5.9.1 Diagnosis 75
5.9.2 Clinical Practice 75
6 Competitive Assessment 77
6.1 Overview 77
6.2 Strategic Competitor Assessment 78
6.3 Product Profiles by Generation 79
6.3.1 Conventional Antipsychotics 79
6.3.2 Atypical Antipsychotics 83
7 Opportunity and Unmet Need 120
7.1 Unmet Needs Overview 120
7.1.1 Public Awareness 121
7.1.2 Early Diagnosis and Treatment 123
7.1.3 Long-Acting and Advanced Drug Delivery Systems 124
7.1.4 Effective Management of Negative and Cognitive Symptom Domains 125
7.2 Gap Analysis 126
7.2.1 Long-Acting Drug Delivery 127
7.2.2 Treatment of Negative and Cognitive Symptoms 127
8 Pipeline Assessment 128
8.1 Overview 128
8.2 Clinical Trial Mapping 129
8.2.1 Clinical Trials by Country 129
8.2.2 Clinical Trials by Phase and Trial Status 130
8.3 Early-Stage Pipeline Assessment 131
8.4 Novel Therapeutic Approaches 132
8.4.1 Negative Symptoms 132
8.4.2 Cognitive Symptoms 132
8.5 Long-Acting Drug Delivery 133
8.6 Technology Trends Analysis 133
8.7 Key Drugs in Clinical Development 134
8.7.1 Aripiprazole Lauroxil 136
8.7.2 Cariprazine 141
8.7.3 Brexpiprazole 145
8.7.4 Zicronapine 149
8.7.5 Bitopertin 152
8.7.6 EVP-6124 156
9 Current and Future Players 160
9.1 Overview 160
9.2 Trends in Corporate Strategy 161
9.3 Company Profiles 161
9.3.1 Janssen Pharmaceuticals 161
9.3.2 Eli Lilly and Company 164
9.3.3 Roche 166
9.3.4 Alkermes 168
9.3.5 EnVivo Pharmaceuticals 170
10 Market Outlook 172
10.1 Global Markets 172
10.1.1 Forecast 172
10.1.2 Global Drivers and Barriers 176
10.2 US 177
10.2.1 Forecast 177
10.2.2 Key Events 181
10.2.3 Drivers and Barriers 181
10.3 France 184
10.3.1 Forecast 184
10.3.2 Key Events 187
10.3.3 Drivers and Barriers 187
10.4 Germany 189
10.4.1 Forecast 189
10.4.2 Key Events 193
10.4.3 Drivers and Barriers 193
10.5 Italy 195
10.5.1 Forecast 195
10.5.2 Key Events 198
10.5.3 Drivers and Barriers 199
10.6 Spain 201
10.6.1 Forecast 201
10.6.2 Key Events 204
10.6.3 Drivers and Barriers 204
10.7 UK 205
10.7.1 Forecast 205
10.7.2 Key Events 208
10.7.3 Drivers and Barriers 208
10.8 Japan 210
10.8.1 Forecast 210
10.8.2 Key Events 213
10.8.3 Drivers and Barriers 213
11 Appendix 216
11.1 Bibliography 216
11.2 Abbreviations 231
11.3 Methodology 236
11.4 Forecasting Methodology 236
11.4.1 Diagnosis and Treatment Rates 236
11.4.2 Adherence Rates 237
11.4.3 Drugs Included in Each Therapeutic Class 237
11.4.4 Launch and Patent Expiry Dates 238
11.4.5 General Pricing Assumptions 239
11.4.6 Drug Assumptions 240
11.4.7 Generic Erosion 247
11.4.8 Pricing of Pipeline Agents 247
11.5 Key Opinion Leaders 249
11.6 About the Authors 250
11.6.1 Author 250
11.6.2 Epidemiology 250
11.6.3 Reviewers 251
11.6.4 Global Head of Healthcare 251
11.7 About GlobalData 252
11.8 Disclaimer 252
【レポート販売概要】
■ タイトル：統合失調症（Schizophrenia）：グローバル医薬品市場動向（～2022）■ 英文：PharmaPoint: Schizophrenia - Global Drug Forecast and Market Analysis to 2022
■ 発行日：2014年2月28日
■ 調査会社：GlobalData
■ 商品コード：GDHC81PIDR
■ 調査対象地域：グローバル
- 庭・芝用ツールの世界市場：芝刈り機、パワーツール、ハンドツール、ガーデンアクセサリーGlobal Garden and Lawn Tools Market: About this market Technavio’s garden and lawn tools market analysis considers sales from both the segments, including residential and commercial. Our analysis also considers the sales of garden and lawn tools in APAC, Europe, North America, South America, and MEA. In 2018, the residential segment had a significant market share, and this trend is expected to con …
- モービルマッピングシステムの世界市場2016-2020About Mobile Mapping A mobile mapping system consists of navigation sensors, moving platforms, and mapping sensors. It provides highly accurate and rich datasets, which are used across industries such as transportation and logistics, retail, manufacturing, telecommunications, and public and real estate. Technavio’s analysts forecast the global mobile mapping market to grow at a CAGR of 14.05% duri …
- ヒトマイクロバイオーム（微生物）の世界市場：プロバイオティクス、プレバイオティクス、食品、医療食、デバイス、薬などNeed for early diagnosis and efficient treatment with microbiome therapy for maintaining healthy lifestyle will boost the human microbiome market The product segment is expected to account for the largest share of the human microbiome market in the coming years. The high growth in this segment is attributed to the expectations to bring promising microbiome products to the market to help individual …
- 非小細胞肺癌治療薬の世界市場2019-2023About this market The increasing prevalence and incidence of non-small cell lung cancer are one of the primary factors driving the global non-small cell lung cancer drugs market growth. The growing risk factors such as cigarette smoking, air pollution, secondary smoking, and occupational exposure is increasing the incidence of non-small cell lung cancer across the world. This will lead to an incre …
- BRIC地域における心臓血管補綴具（装置）の市場動向（～2020）BRIC Cardiovascular Prosthetic Devices Market Outlook to 2020 Summary GlobalData’s new report, "BRIC Cardiovascular Prosthetic Devices Market Outlook to 2020", provides key market data on the BRIC Cardiovascular Prosthetic Devices market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Cardiac Valve Repa …
- 世界の石油及び化学品貯蔵市場2014：計画、投資機会、分析等Global Planned Oil and Chemicals Storage Industry, 2014 - Investment Opportunities, Analysis and Forecasts of All Planned Terminals Summary “Global Planned Oil and Chemicals Storage Industry, 2014 - Investment Opportunities, Analysis and Forecasts of All Planned Terminals”, is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the global …
- 自動車インテリジェント照明システムの世界市場2018-2022About Automotive Intelligent Lighting System An automotive intelligent lighting system is a highly adaptive or automatically controlled automotive light system, which helps in increasing the safety while driving or creating a comfortable environment through lighting. Technavio’s analysts forecast the global automotive intelligent lighting system market to grow at a CAGR of 7.83% during the period …
- TD-LTE市場動向 : 世界主要国の導入状況と課題The TD-LTE ecosystem is still in its early days but the commercial launch by China Mobile in December 2013 is going to boost the TD-LTE market. Our estimates for TD-LTE subscriptions in December 2013, based on the data from our LTE Watch service, indicate fewer than 3.5 million subscriptions. This report presents the TD-LTE deployment status in the main markets (Japan, USA, China, Australia, India …
- PCB・MCM向け電子設計自動化（EDA）の世界市場2016-2020About EDA EDA tools are used in the designing of electronic systems. The range of products where these tools can be used is extremely wide as it can vary for the chips that are used in computers or mobile devices and satellites. An MCM is usually an electronic assembly where multiple integrated circuits (ICs), semiconductor dies, and other discrete components are integrated, generally on a unifyin …
- 大便失禁(Fecal Incontinence)：世界の治験レビュー（2015年上半期版）Fecal Incontinence Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Fecal Incontinence Global Clinical Trials Review, H1, 2015" provides data on the Fecal Incontinence clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Fecal Incontinence. It includes an overview of the trial numbers and their recruitme …
- 新生児発作治療のグローバル臨床試験動向（2014年H2）Neonatal Seizures Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Neonatal Seizures Global Clinical Trials Review, H2, 2014" provides data on the Neonatal Seizures clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Neonatal Seizures. It includes an overview of the trial numbers and their recruitment s …
- 世界のエンタープライズ・ソーシャルネットワーク市場動向（2012-2016）TechNavio's analysts forecast the Global Enterprise Social Networking Software market to grow at a CAGR of 51.94 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased requirement of intranet interactivity among multiple teams in an organization. The market has also been witnessing an increased use of mobile enterprise social networking for sa …
- 世界の通信運用管理市場動向（2012-2016）TechNavio's analysts forecast the Global Telecom Operation Management market to grow at a CAGR of 3.76 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing adoption of next-generation telecom technologies. Global Telecom Operation Management market has also been witnessing the rise in automation of network management tools. However, the dec …
- 民間航空機用アビオニクスの世界市場2015-2019About Commercial Aircraft Avionics Systems Avionics are electronics systems used in aircraft for communication, navigation, and various other flight critical applications. Avionics are one of the most expensive and highly critical components in modern aircraft. Modern avionics also aid in improved navigation and routing, provide enhanced situational awareness to pilots, and improve the ATM process …
- Stelara（クローン病治療薬）：市場予測及び分析（～2022）Stelara (Crohn’s Disease) - Forecast and Market Analysis to 2022 Summary The Crohn’s disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds will challenge the current biologics in an attempt to dislodge the stronghold of the TNF inhibitors, as they aim to tap into the lucrative portion of the CD therapeutics market. If their promising safety an …
